[Form 4] AGILYSYS INC Insider Trading Activity
Agilysys, Inc. (AGYS) reported an insider transaction: the Chief Financial Officer sold 6,000 shares of common stock on 10/27/2025, coded “S” for sale.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
Agilysys, Inc. (AGYS) reported an insider transaction: the Chief Financial Officer sold 6,000 shares of common stock on 10/27/2025, coded “S” for sale. The weighted average price was $115.55, with individual trades executed between $113.85 and $117.04.
Following the sale, the reporting person beneficially owned 41,288 shares, held directly. The filing notes the price is a weighted average and that full breakdowns of each trade price within the stated range are available upon request.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Sale | Common Stock | 6,000 | $115.55 | $693K |
Footnotes (1)
- F1. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $113.85 to $117.04. The reporting person undertakes to provide to Agilysys, Inc., any security holder of Agilysys, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within this range.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What insider transaction did AGYS disclose on Form 4?
What was the sale price for the AGYS insider transaction?
What transaction code was used in the AGYS Form 4?
Did the AGYS Form 4 specify direct or indirect ownership?
Does the filing provide detail for each trade price?
AI-generated analysis. How Rhea-AI works. Not financial advice.